ArticleCureus2026
Testimonial Injustice and Its Harms in Hemodialysis Patients in Japan: A Qualitative Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study explored testimonial injustice and its associated harms arising from prejudices experienced by patients undergoing hemodialysis and examined implications for bioethics. Methods We conducted semi-structured interviews with 23 patients undergoing hemodialysis for one year or more. The interviews focused on the patients' experiences of prejudice, how they addressed the prejudice, and the effects of the prejudice. We analyzed the interviews by content analysis using Krippendorff's method. Results The analysis identified multiple forms of prejudice across both clinical and non-clinical settings. Patterns consistent with testimonial injustice were also observed, including situations in which patients were not believed or were not given opportunities to speak. In response, some participants adopted anticipatory strategies to avoid prejudice, such as withholding or modifying their testimony. These accounts correspond to testimonial smothering, in which individuals suppress their own statements in anticipation of negative evaluation. The harms identified in the data were primarily medical disadvantages, such as delayed examinations and treatment, which affected patients' access to appropriate care. Conclusion This study demonstrated that testimonial injustice can occur among individuals with internal disabilities whose conditions are not outwardly visible. Some patients anticipated this injustice and engaged in avoidance behaviors, such as concealing their treatment status, thereby forfeiting opportunities to be recognized as legitimate subjects of knowledge. The harms associated with these experiences included both primary and secondary forms: primary harms were identified as "invisible harms" that may threaten patients' dignity and warrant consideration under the principle of nonmaleficence, while secondary harms raised concerns from the perspective of formal justice. Addressing testimonial injustice in bioethics may help clarify how patients are harmed when their words are not taken seriously and encourage healthcare professionals to reflect on how they listen to and respond to patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.